Characterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps

BMC Physiology

Volumn 11, Issue 1, 2011, Pages

  Qi, Yong ^a   Longo, Kenneth A ^a   Giuliana, Derek J ^a   Gagne, Samantha ^a   McDonagh, Tom ^a   Govek, Elizabeth ^a   Nolan, Anna ^a   Zou, Chaoseng ^a   Morgan, Kristen ^a   Hixon, Jeffrey ^a   Saunders, Jeffrey O ^a   DiStefano, Peter S ^a   Geddes, Brad J ^a  

^a Elixir Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN RECEPTOR; INSULIN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; FAT INTAKE; GENETICS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; INSULIN RESISTANCE; LIVER; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT;

ANIMALS; DIETARY FATS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, GHRELIN;

EID: 78650869242     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-11-1     Document Type: Article

References (33)

1. Acute effects of ghrelin administration on glucose and lipid metabolism. ET Vestergaard CB Djurhuus J Gjedsted S Nielsen N Moller, et al. J Clin Endocrinol Metab 2008 93 438 444 10.1210/jc.2007-2018 18042651
2. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. KA Longo S Charoenthongtrakul DJ Giuliana EK Govek T McDonagh, et al. Regul Pept 2008 18453014
3. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Y Sun M Asnicar PK Saha L Chan RG Smith, Cell Metab 2006 3 379 386 10.1016/j.cmet.2006.04.004 16679295
4. Mice lacking ghrelin receptors resist the development of diet-induced obesity. JM Zigman Y Nakano R Coppari N Balthasar JN Marcus, et al. J Clin Invest 2005 115 3564 3572 10.1172/JCI26002 16322794
5. Absence of ghrelin protects against early-onset obesity. KE Wortley JP del Rincon JD Murray K Garcia K Iida, et al. J Clin Invest 2005 115 3573 3578 10.1172/JCI26003 16322795
6. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J Rudolph WP Esler S O'Connor PD Coish PL Wickens, et al. J Med Chem 2007 50 5202 5216 10.1021/jm070071+ 17887659
7. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. WP Esler J Rudolph TH Claus W Tang N Barucci, et al. Endocrinology 2007 148 5175 5185 10.1210/en.2007-0239 17656463
8. Ghrelin induces adiposity in rodents. M Tschop DL Smiley ML Heiman, Nature 2000 407 908 913 10.1038/35038090 11057670
9. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. HM Lee G Wang EW Englander M Kojima GH Greeley Jr, Endocrinology 2002 143 185 190 10.1210/en.143.1.185 11751608
10. Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach. SG Moesgaard B Ahren RD Carr DX Gram CL Brand, et al. Regul Pept 2004 120 261 267 10.1016/j.regpep.2004.03.018 15177945
11. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. KD Chavin S Yang HZ Lin J Chatham VP Chacko, et al. J Biol Chem 1999 274 5692 5700 10.1074/jbc.274.9.5692 10026188
12. [Expression of uncoupling protein 2 and its relationship to the content of adenosine triphosphate in the nonalcoholic fatty livers of rats fed a high-fat diet]. JG Fan XD Ding GL Wang ZJ Xu LY Tian, et al. Zhonghua Gan Zang Bing Za Zhi 2005 13 374 377 15918975
13. Mitochondrial adaptations to obesity-related oxidant stress. S Yang H Zhu Y Li H Lin K Gabrielson, et al. Arch Biochem Biophys 2000 378 259 268 10.1006/abbi.2000.1829 10860543
14. Superoxide activates mitochondrial uncoupling proteins. KS Echtay D Roussel J St-Pierre MB Jekabsons S Cadenas, et al. Nature 2002 415 96 99 10.1038/415096a 11780125
15. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. MD Brand TC Esteves, Cell Metab 2005 2 85 93 10.1016/j.cmet.2005.06.002 16098826
16. Mitochondrial involvement in non-alcoholic steatohepatitis. G Serviddio J Sastre F Bellanti J Vina G Vendemiale, et al. Mol Aspects Med 2008 29 22 35 10.1016/j.mam.2007.09.014 18061659
17. Uncoupling proteins, dietary fat and the metabolic syndrome. JS Fisler CH Warden, Nutr Metab (Lond) 2006 3 38 10.1186/1743-7075-3-38 16968550
18. Modeling phasic insulin release: immediate and time-dependent effects of glucose. R Nesher E Cerasi, Diabetes 2002 51 Suppl 1 53 59 10.2337/diabetes.51. 2007.S53 11815459
19. High fat diet modulation of glucose sensing in the beta-cell. ME Cerf, Med Sci Monit 2007 13 A12 17 17179917
20. Nonalcoholic fatty liver disease. P Angulo, N Engl J Med 2002 346 1221 1231 10.1056/NEJMra011775 11961152
21. Molecular mediators of hepatic steatosis and liver injury. JD Browning JD Horton, J Clin Invest 2004 114 147 152 15254578
22. Mouse models of insulin resistance. A Nandi Y Kitamura CR Kahn D Accili, Physiol Rev 2004 84 623 647 10.1152/physrev.00032.2003 15044684
23. Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review. NC Chavez-Tapia T Barrientos-Gutierrez FI Tellez-Avila F Sanchez-Avila MA Montano-Reyes, et al. World J Gastroenterol 2006 12 7826 7831 17203528
24. Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARalpha-mediated pathway. MB Armstrong HC Towle, Am J Physiol Endocrinol Metab 2001 281 1197 1204 11701434
25. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. O Boss E Bobbioni-Harsch F Assimacopoulos-Jeannet P Muzzin R Munger, et al. Lancet 1998 351 1933 10.1016/S0140-6736(05)78617-7 9654269
26. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. T Yasuda T Masaki T Kakuma H Yoshimatsu, Neurosci Lett 2003 349 75 78 10.1016/S0304-3940(03)00789-4 12946556
27. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. T Tsubone T Masaki I Katsuragi K Tanaka T Kakuma, et al. Regul Pept 2005 130 97 103 10.1016/j.regpep.2005.04.004 15946750
28. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Y Sun P Wang H Zheng RG Smith, Proc Natl Acad Sci USA 2004 101 4679 4684 10.1073/pnas.0305930101 15070777
29. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. JC Henquin M Nenquin P Stiernet B Ahren, Diabetes 2006 55 441 451 10.2337/diabetes.55.02.06.db05-1051 16443779
30. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. CR Cederroth M Vinciguerra A Gjinovci F Kuhne M Klein, et al. Diabetes 2008 57 1176 1185 10.2337/db07-0630 18420492
31. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice. JK Kim JJ Fillmore O Gavrilova L Chao T Higashimori, et al. Diabetes 2003 52 1311 1318 10.2337/diabetes.52.6.1311 12765938
32. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. SJ Fisher CR Kahn, J Clin Invest 2003 111 463 468 12588884
33. Regulation of gluconeogenesis by Kruppel-like factor 15. S Gray B Wang Y Orihuela EG Hong S Fisch, et al. Cell Metab 2007 5 305 312 10.1016/j.cmet.2007. 03.002 17403374